Virginia R. G.
- Country
- Spain
- Department
- Neurology
Research Overview
- A Phase 2b Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Usnoflast in Adults with Amyotrophic Lateral Sclerosis
- Phase 3 Randomized Double-Blind Trial of Riliprubart Versus Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy
- Evaluation of Gefurulimab (ALXN1720) Efficacy and Safety in Adults with Generalized Myasthenia Gravis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 50 of 146 partner sites.
Specializations
Neuroimmunology and neurological autoimmune disease
Virginia Reyes Garrido’s clinical research activity includes multiple sclerosis, myasthenia gravis, autoimmune encephalitis, chronic inflammatory demyelinating polyneuropathy, and myelin oligodendrocyte glycoprotein antibody-associated disease, with a strong therapeutic interest in immune-mediated disorders of the central nervous system and peripheral nerve.
- Relapsing and progressive multiple sclerosis
- Generalized myasthenia gravis
- Autoimmune encephalitis
- Chronic inflammatory demyelinating polyneuropathy
- MOG antibody-associated disease
The investigator is also involved in studies addressing neurologic disability, seizure disorders, and neuroinflammatory disease control.
Epilepsy and seizure disorders
Another major area of interest is epileptology, including focal epilepsy, primary generalized tonic-clonic seizures, developmental and epileptic encephalopathies, and syndromic forms such as Dravet syndrome, Lennox-Gastaut syndrome, and tuberous sclerosis complex-related epilepsy.
- Focal onset seizures
- Primary generalized tonic-clonic seizures
- Developmental and epileptic encephalopathies
- Dravet syndrome
- Tuberous sclerosis complex-related epilepsy
Her trial portfolio reflects involvement in therapies aimed at improving seizure control and reducing the burden of refractory epilepsy.
Oncology and solid tumor therapeutics
Virginia Reyes Garrido is extensively engaged in clinical research on lung cancer, especially non-small cell lung cancer and small cell lung cancer, alongside melanoma, breast cancer, colorectal cancer, pancreatic cancer, head and neck cancer, and urothelial carcinoma.
- Non-small cell lung cancer
- Small cell lung cancer
- Melanoma
- Breast cancer
- Gastrointestinal and pancreatic malignancies
Her research interests also extend to targeted therapy, immunotherapy, and treatment strategies for advanced or metastatic solid tumors.
Autoimmune, inflammatory, and allergic disease
The investigator’s portfolio includes rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren’s syndrome, bullous pemphigoid, Crohn’s disease, ulcerative colitis, and chronic spontaneous urticaria, reflecting interest in immune-mediated inflammatory conditions.
- Rheumatoid arthritis
- Psoriatic arthritis
- Systemic lupus erythematosus
- Inflammatory bowel disease
- Allergic rhinitis and urticaria
She is also involved in therapeutic areas covering asthma, atopic dermatitis, and other immune dysregulation disorders.
Rare disease, hematology, and cardiorenal conditions
Her clinical trial activity further includes hemophilia, myelodysplastic syndrome, multiple myeloma, acute leukemia, kidney transplant-related complications, IgA nephropathy, chronic kidney disease, and selected cardiovascular disease settings.
- Hemophilia A and B
- Multiple myeloma
- Acute and chronic leukemias
- IgA nephropathy
- Cardiovascular and renal disease
Additional interests include transplant medicine, metabolic disease, and rare genetic disorders associated with neurologic or systemic involvement.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.